 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
As PacBio Orders Decline in Q1, Company Bets on Happy Customers for Future Sales
May 08, 2012
As PacBio Orders Decline in Q1, Company Bets on Happy Customers for Future Sales
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Booking 6 Systems in Q4, PacBio Begins C2 Upgrades, Will Focus on Niche Applications
February 14, 2012 / In Sequence - PacBio Bets on RS II to Drive Future Orders as Q1 Revenues Slide 44 Percent
April 30, 2013 / In Sequence - PacBio Sales Start to Pick Up as Company Delivers on Product Enhancements
February 12, 2013 / In Sequence - PacBio Books Four Systems in Q3; Plans Q4 Chemistry Upgrade to Enable Longer Average Read Length
October 29, 2012 / In Sequence - PacBio Books One New Instrument in Q2; Will Focus on Epigenetic and Assembly Applications
July 31, 2012 / In Sequence